Tonix Pharmaceuticals (TNXP) Misses Q4 EPS by 5c

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q4 EPS of ($0.71), $0.05 worse than the analyst estimate of ($0.66).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

You May Also Be Interested In

• Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
• X Financial (XYF) Tops Q2 EPS by 438c
• This S&P 500 sector offers the best hedge against rising oil prices